CLPTM1L and cancer: Using high-density genotyping, imputation, a ‘global’ likelihood test and multi-SNP logistic regression analyses, we have shown for the first time that genetic variants in the TERT–CLPTM1L region are associated with the risk of endometrial cancer, and provide evidence that this region contains three independent risk SNPs for this cancer.